angiotensin ii has been researched along with Acute Disease in 175 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 77 (44.00) | 18.7374 |
| 1990's | 39 (22.29) | 18.2507 |
| 2000's | 34 (19.43) | 29.6817 |
| 2010's | 20 (11.43) | 24.3611 |
| 2020's | 5 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseini, M; Kamkar-Del, Y; Khajavirad, A; Mohebbati, R; Rakhshandeh, H; Shafei, MN | 1 |
| Liu, R; Xin, LH; Yang, XW | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Kamkar-Del, Y; Mohebbati, R; Shafei, MN | 1 |
| Chan, YH; Chen, SW; Chou, AH; Chou, SH; Chu, PH; Ho, CT; Hsiao, FC; Hsu, ME; Kao, WWY; Lin, PJ; Tung, YC; Wu, VC | 1 |
| Abu-Izneid, T; Khan, H; Patel, S; Rauf, A | 1 |
| Collawn, JF; Dell'Italia, LJ; Ferrario, CM | 1 |
| Fujita, T; Ishigami, T; Ishikawa, Y; Kimura, K; Narikawa, M; Tamura, K; Tanaka, R; Umemura, M; Yokoyama, U | 1 |
| Milewicz, DM; Ramirez, F | 1 |
| Dai, WY; Hu, W; Ke, XF; Lin, HP; Liu, BW; Su, J; Xi, SS; Yang, J; Zeng, XK; Zhu, ML; Zhu, Y | 1 |
| Cao, XY; Chen, J; Shu, Y | 1 |
| Jha, RK; Liu, C; Luo, X; Ma, Q; Ma, Z; Qingyuan, Z; Sha, H; Wang, Z; Wu, Z | 1 |
| Fujimura, T; Fujita, H; Furukawa, H; Fushida, S; Hayashi, H; Inokuchi, M; Iseki, S; Kitagawa, H; Makino, I; Miyashita, T; Nakagawara, H; Nakamura, K; Nakanuma, S; Ninomiya, I; Ohta, T; Okamoto, K; Oyama, K; Sakai, S; Shinmura, A; Tajima, H; Takamura, H; Tsukada, T; Wakayama, T | 1 |
| Horiuchi, M; Kawajiri, M; Matsumoto, S; Mogi, M; Tsukuda, K; Yamada, T | 1 |
| Cui, L; Liu, R; Qi, H; Wang, J; Wang, Y; Wen, Y; Yin, C | 2 |
| Anzai, A; Endo, J; Fukuda, K; Ito, K; Katsumata, Y; Kohno, T; Matsuhashi, T; Okada, Y; Sano, M; Shimizu-Hirota, R; Shimoda, M; Shinmura, K; Shirakawa, K; Ueha, S; Yamada, Y; Yamamoto, T; Yan, X | 1 |
| Anzai, J; Sano, M | 1 |
| Dobashi, S; Hisatake, S; Ikeda, T; Kabuki, T; Kiuchi, S; Oka, T | 1 |
| Chen, Y; Du, YQ; Guo, JF; Guo, XR; Li, ZS; Yu, QH | 1 |
| Felder, RB; Wei, SG; Weiss, RM; Yu, Y; Zhang, ZH | 1 |
| Kawasaki, H; Kitamura, Y; Mio, M; Miyashita, S; Takatori, S; Yamawaki, K; Zamami, Y | 1 |
| Lee, DH; Leong, PK; Maunsbach, AB; McDonough, AA; Riquier, AD; Yang, LE | 1 |
| Chen, SS; Chen, WC; Chien, CT; Hayakawa, S; Li, PC | 1 |
| Chu, Y; Heistad, DD; Miller, JD; Rosenberg, GA; Wakisaka, Y | 1 |
| Cecconello, AL; Lucion, AB; Raineki, C; Sanvitto, GL; Sebben, V | 1 |
| Djurhuus, JC; Hagstroem, S; Kamperis, K; Radvanska, E; Rittig, S | 1 |
| Boerrigter, G; Burnett, JC; Cataliotti, A; Chen, HH; Ichiki, T; Martin, FL; McKie, PM; Sangaralingham, SJ | 1 |
| Adachi, T; Aikawa, N; Hori, S; Itoh, H; Kurihara, T; Okada, Y; Shimizu, H; Shimizu-Hirota, R; Shimoda, M; Weiss, SJ | 1 |
| Djurhuus, JC; Frøkiaer, J; Hvistendahl, JJ; Pedersen, EB; Pedersen, TS | 1 |
| Boemke, W; Francis, RC; Höhne, C; Kaczmarczyk, G | 1 |
| Holstein-Rathlou, NH; Leong, PK; McDonough, AA; Yang, LE; Zhang, Y | 1 |
| Holstein-Rathlou, NH; Leong, PK; McDonough, AA; Yang, LE | 1 |
| Bradley, WE; Dell'Italia, LJ; Lucchesi, PA; Powell, PC; Tallaj, J; Wei, CC | 1 |
| Bottoms, SE; Chambers, RC; Gohlke, P; Howell, DC; Laurent, GJ; Marshall, RP; McAnulty, RJ; Unger, T | 1 |
| Abe, Y; Kimura, S; Nishiyama, A; Rahman, M; Shokoji, T; Zhang, GX | 1 |
| Brunner, HR; Burnier, M; Chiclero, A; Chioléro, A; Maillard, M; Nussberger, J; Wuerzner, G | 1 |
| Baffoni, L; Durante, V; Grossi, M | 1 |
| Luft, FC | 1 |
| Ergul, A; Fagan, SC; Hess, DC; Hohnadel, EJ; Pollock, DM | 1 |
| Brands, MW; Fleming, C; Lee, DL; Leite, R; Pollock, JS; Webb, RC | 1 |
| Hasebe, N; Izawa, K; Jin, YT; Kido, S; Kikuchi, K; Natori, S; Ohta, T; Sato, M; Tsuji, S | 1 |
| Crackower, MA; Fukamizu, A; Guan, B; Guo, F; Hein, L; Huan, Y; Hui, CC; Imai, Y; Jiang, C; Kuba, K; Leong-Poi, H; Penninger, JM; Rao, S; Sarao, R; Slutsky, AS; Uhlig, S; Wada, T; Yang, P | 1 |
| Alcantara, C; Brito, GA; Carvalho, RF; Cunha, FQ; Falcão, RA; Leitão, RF; Lima, RC; Ribeiro, RA; Souza, MH | 1 |
| Kim, YH; Klein, JD; Murrell, BP; Sands, JM; Tucker, S | 1 |
| Grassi, G | 1 |
| Aro, J; Ruskoaho, H; Rysä, J | 1 |
| Azuma, J; Dosaka, N; Iekushi, K; Katsuragi, N; Koibuchi, N; Morishita, R; Nagao, K; Ogihara, T; Sanada, F; Taniyama, Y | 1 |
| Anselmo-Franci, JA; Corezola, KL; Donadio, MV; Franci, CR; Kunrath, A; Lucion, AB; Sanvitto, GL | 1 |
| Gavras, H; Liang, C | 1 |
| Amery, A; Billiet, L; Fagard, R; Lijnen, P; Reybrouck, T | 1 |
| Davenport, MW; Davis, CL; Horton, R; Martin, KL; Swinney, RR; Tuck, ML; Warner, NE; Zipser, RD | 1 |
| Davenport, MW; Zipser, RD | 1 |
| Decoodt, P; Devriendt, J; Staroukine, M; Verniory, A | 1 |
| Bing, RF; Mistry, M; Swales, JD; Thurston, H | 1 |
| Dietz, R; Ganten, D; Mann, JF; Ritz, E | 1 |
| Fechner, C; Finestone, H; Levy, M | 1 |
| Oztaş, B; Sandalci, U | 1 |
| Heptinstall, RH; Wilson, SK | 1 |
| Glassock, RJ | 1 |
| Glänzer, K; Vetter, H; Vetter, W; Witassek, F; Wollnik, S; Zumkley, H | 1 |
| Augustin, HJ; Engels, T; Huland, H | 1 |
| Anderson, RJ; Dillingham, MA; Gross, PA; Henrich, WL | 1 |
| Giacomelli, F; Grammas, P; Wiener, J | 1 |
| Bairey, N; Oparil, S; Szidon, P | 1 |
| Lowenberg, F; Osorio, J; Pommier, M; Rodríguez, C | 1 |
| Greenbaum, LM; Leuenberger, PJ; Mellins, RB; Stalcup, SA; Turino, GM | 1 |
| Baboolal, K; Meyer, TW | 1 |
| Martinez-Maldonado, M; Pimentel, JL; Wang, S | 1 |
| Angus, RM; Connell, JM; Hulks, G; Millar, EA; Morton, JJ; Thomson, NC | 1 |
| Carey, RM; Peach, MJ; Rose, CE | 1 |
| Bussone, M; Caspers, ML; Dow, MJ; Grammas, P; Ulanski, LJ | 1 |
| Abman, SH; Cornfield, DN; McMurtry, IF; Rodman, DM; Stevens, T | 1 |
| Obika, LF | 1 |
| Donald, RA; Espiner, EA; Livesey, JH; Richards, AM; Wittert, GA; Yandle, TG | 1 |
| Guignard, JP; Huet, F; John, E; Semama, D | 1 |
| Burnett, JC; Cavero, PG; Fett, DL | 1 |
| Jennings, DB; Ohtake, PJ; Walker, JK | 1 |
| Jennings, DB; Walker, JK | 1 |
| Gorospe, M; Holbrook, NJ; Liu, Y; Udelsman, R; Xu, Q | 1 |
| el-Dahr, S; Martínez-Maldonado, M; Montero, A; Pimentel, JL; Wang, S; Yosipiv, I | 1 |
| Kass, DA; Recchia, FA; Saeki, A; Tunin, RS | 1 |
| Iijima, Y; Ishigooka, M; Kubota, Y; Nakada, T; Suzuki, H; Watanabe, M | 1 |
| Blaine, EH; Dale, WE; Hasser, EM; Li, Q | 1 |
| Li, C; Li, L; Li, X; Lü, X; Wang, H | 1 |
| Assmann, KJ; de Jong, AS; Dijkman, HB; Koene, RA; Mentzel, S; van Son, JP; Wetzels, JF | 1 |
| Morrell, NW | 1 |
| Fawcett, TW; Gorospe, M; Guyton, KZ; Holbrook, NJ; Liu, Y; Xu, Q | 1 |
| Ding, YA; Lee, YM; Peng, YY; Yen, MH | 1 |
| Fukuda, K; Hori, S; Kodama, H; Makino, S; Ogawa, S; Pan, J; Sano, M; Takahashi, T | 1 |
| Dagg, KD; Lipworth, BJ; McKay, IC; McSharry, C; Ramsay, SG; Thomson, NC | 1 |
| Bowes, MP; Fagan, SC; Lyden, PD; Zivin, JA | 1 |
| Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S | 1 |
| Abe, I; Fujishima, M; Kagiyama, S; Liu, Y; Matsumura, K; Tsuchihashi, T | 1 |
| Komatsu, R; Ueda, M | 1 |
| Carey, RM; Heiderstadt, NT; Johns, RA; Millatt, LJ; Siragy, HM; Wang, ZQ | 1 |
| Bernier, NJ; Kaiya, H; Perry, SF; Takei, Y | 1 |
| Aneman, A; Bengtsson, J; Fändriks, L; Holm, M; Pettersson, A; Snygg, J | 1 |
| Bader, M; Hata, R; Hossmann, KA; Maeda, K; Walther, T | 1 |
| Georgiev, V; Opitz, M | 1 |
| Just, H | 1 |
| Meyer, TW; Olson, JL; Pagtalunan, ME | 1 |
| Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A | 1 |
| Llinás, MT; Moreno, C; Nava, E; Rodríguez, F; Salazar, FJ | 1 |
| Iwao, H; Izumi, Y; Kim, S; Namba, M; Yasumoto, H; Zhan, Y | 1 |
| Stocker, SD; Stricker, EM; Sved, AF | 1 |
| Arntz, E; Boemke, W; Höhne, C; Kaczmarczyk, G; Krebs, MO | 1 |
| Galli, SM; Phillips, MI | 1 |
| Levi, M; Moons, AH; Peters, RJ | 1 |
| Bao, D; Gan, H; Huang, W; Jin, Z; Wu, S; Yang, Y | 1 |
| Johansson, BB; Linder, LE | 1 |
| Johansson, BB; Martinsson, L | 1 |
| Chernukh, AM; Gomazkov, OA; Shimkovich, MV | 1 |
| Kokot, F | 1 |
| Isaev, MR; Tenedieva, VD | 1 |
| Kokkonen, J; Männistö, PT; Ranta, T | 1 |
| Carretero, OA; Gulati, OP | 1 |
| Davis, JO; DeForrest, JM; Freeman, RH; Stephens, GA; Watkins, BE | 1 |
| Rossel's, AN; Salem, S | 1 |
| Balfe, JW; Guyton, AC; Hall, JE; McCaa, RE; Salgado, HC | 1 |
| Aisenbrey, G; Burke, TJ; Cadnapaphornchai, P; McDonald, KM; Schrier, RW | 1 |
| Dinsdale, HB; Nag, S; Robertson, DM | 1 |
| Gillenwater, JY; Moody, TE; Vaughan, ED; Wyker, AT | 1 |
| Booker, WM; Fletcher, A; Hawthorne, D; Hyde, A | 1 |
| Johansson, BB; Siesjö, BK | 1 |
| Olsen, F | 2 |
| Henning, M; Johansson, B | 1 |
| Thorball, N | 1 |
| Crexells, C; Diamond, G; Forrester, JS; Parmley, WW; Tomoda, H | 1 |
| Ledingham, JM | 1 |
| Brown, MJ; Cain, MD; Katic, FP; Scoop, GC; Zeegers, PJ | 1 |
| Kravchun, PG; Mikliaev, IIu; Rachinskiĭ, ID; Shushliapin, OI; Vlasenko, MA | 1 |
| Schölkens, BA | 2 |
| Anderson, WH; Datta, J; Samols, E | 1 |
| Bill, A; Linder, J | 1 |
| Elg, M; Fyhrquist, F; Gustafsson, D; Hedner, T; Johnsson, E; Sohtell, M; Svensson, L | 1 |
| Brashers, VL; Carey, RM; Dacus, WS; Peach, MJ; Rose, CE; Vance, JE | 1 |
| Adler, G; Feddersen, CO; Karges, W; Püchner, A; Wichert, PV; Willemer, S | 1 |
| Arnolda, L; Johnston, CI; McGrath, BP | 1 |
| Malinovskaia, IE; Popova, LI; Reĭko, MN; Savitskiĭ, SIu; Shumakov, VA; Tashchuk, VK | 1 |
| Wilson, SK | 1 |
| Itaya, Y; Kumagai, H; Matsukawa, S; Saruta, T; Suzuki, H | 1 |
| Christensen, NJ; Henriksen, JH; Kastrup, J | 1 |
| Broqvist, M; Dahlström, U; Karlberg, BE; Karlsson, E; Marklund, T | 1 |
| Salgado, HC; Salgado, MC | 1 |
| Fechner, C; Levy, M | 1 |
| Bagshaw, RJ; Cox, RH | 1 |
| Maruyama, K; Mullen, M; O'Brodovich, H; Olley, PM; Rabinovitch, M; Rosenberg, HC | 1 |
| Fujishima, M; Hirakata, H; Hori, K; Onoyama, K | 1 |
| Olson, NC | 1 |
| Ma, ZS | 1 |
| Dzau, VJ; Gibbons, GH; Nabel, EG | 1 |
| Anderson, GH; Haas, DC; Streeten, DH | 1 |
| Anderson, WP; Kline, RL; Woods, RL | 1 |
| Skinhoj, E; Strandgaard, S | 1 |
| Rasenack, U; Wünsch, PH | 1 |
| Bumpus, FM; Sen, S; Smeby, RR | 1 |
| de Jong, W | 1 |
| Agnoli, A; Battistini, N; Bozzao, L; Fieschi, C; Prencipe, M | 1 |
| Gliedman, ML; Mullane, JF | 1 |
| Dahn, I; Hallböök, T; Larsen, OA; Lassen, NA; Nilsén, R; Westling, H | 1 |
| Greenway, CV; Stark, RD | 1 |
| Markov, KhM | 1 |
| Brody, MJ; Kadowitz, PJ; Sweet, CS | 1 |
| Dabels, J; Kochan, E; Sievers, P; Wendel, H | 1 |
| Michel, H; Seki, A; Wernze, H | 1 |
| Farrell, P; Fitzgerald, O; Fitzgerald, P; Geoghegan, C; Heffernan, A; McGeeney, K | 1 |
| Chand, S; Crosby, UD; Gant, NF; MacDonald, PC; Whalley, PJ; Worley, RJ | 1 |
| Hoobler, SW; Mak, SW; Romero, JC | 1 |
| Eto, T; Omae, T; Oniki, H; Onoyama, K; Tanaka, K | 1 |
| Aluli, E; Cockett, AT; Davis, RS | 1 |
| Battistini, N; Beduschi, A; Boselli, L; Fieschi, C; Rossanda, M | 1 |
| Kaneko, Y; McCubbin, JW; Page, IH | 1 |
14 review(s) available for angiotensin ii and Acute Disease
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.
Topics: Acute Disease; Angiotensin II; Chronic Disease; Homeostasis; Humans; Inflammation; Renin; Renin-Angiotensin System | 2017 |
Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cardiovascular Diseases; Chronic Disease; Chymases; Enzyme Inhibitors; Humans; Mast Cells; Renin-Angiotensin System; Vascular Remodeling | 2018 |
Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections.
Topics: Acute Disease; Angiotensin II; Animals; Aortic Aneurysm, Thoracic; Aortic Dissection; Humans; Losartan; Mice; Signal Transduction; Transforming Growth Factor beta | 2019 |
The molecular mechanisms contributing to the pathophysiology of systemic inflammatory response after acute aortic dissection.
Topics: Acute Disease; Angiotensin II; Animals; Aorta; Aortic Aneurysm; Aortic Dissection; Chemokines; Gene Expression; Humans; Immune System Diseases; Interleukin-6; Interleukin-8; Leukocyte Disorders; Mice; Molecular Targeted Therapy; Neutrophils; Receptors, Interleukin-8B; Systemic Inflammatory Response Syndrome | 2016 |
Targets for vascular protection after acute ischemic stroke.
Topics: Acute Disease; Angiopoietins; Angiotensin II; Antioxidants; Apoptosis; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Arteries; Cerebral Hemorrhage; Chronic Disease; Endothelin-1; Endothelium, Vascular; Humans; Inflammation Mediators; Matrix Metalloproteinases; Neuroprotective Agents; Neutrophils; Oxidative Stress; Reactive Oxygen Species; Vascular Endothelial Growth Factor A; Vasculitis | 2004 |
Sodium homeostasis in acute glomerulonephritis and the nephrotic syndrome.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Blood Volume; Glomerular Filtration Rate; Glomerulonephritis; Homeostasis; Humans; Kidney; Nephrotic Syndrome; Plasma Volume; Renin; Sodium; Water-Electrolyte Imbalance | 1980 |
Acute renal failure.
Topics: Acute Disease; Acute Kidney Injury; Adenosine; Age Factors; Angiotensin II; Animals; Animals, Newborn; Blood Flow Velocity; Calcium Channels; Disease Models, Animal; Endothelins; Free Radicals; Glomerular Filtration Rate; Humans; Hypoxia; Infant, Newborn; Rabbits; Reactive Oxygen Species; Renal Circulation; Risk Factors | 1993 |
[Plaque progression and destabilization in human coronary arteries].
Topics: Acute Disease; Angiotensin II; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Endothelial Growth Factors; Humans; Lymphokines; Peptidyl-Dipeptidase A; Syndrome; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
[Therapy for heart failure].
Topics: Acute Disease; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Diuretics; Heart Failure; Humans; Vasodilator Agents | 2000 |
Tissue factor and coronary artery disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin | 2002 |
Experimental renal hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Autonomic Nervous System; Body Fluids; Chronic Disease; Constriction; Heart; Hemodynamics; History, 20th Century; Humans; Hypertension, Renal; Kidney; Myocardium; Nephrectomy; Neurons, Efferent; Plasma Volume; Pressoreceptors; Renal Artery; Renin; Sodium; Vascular Resistance; Vasomotor System | 1975 |
Pathophysiology of experimental renovascular hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Arterial Occlusive Diseases; Central Nervous System; Chronic Disease; Disease Models, Animal; Dogs; Hemodynamics; Hypertension, Renovascular; Kidney; Ouabain; Perfusion; Rats; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstriction; Vasopressins | 1985 |
[Neurogenic mechanisms in the pathogenesis of renal hypertension].
Topics: Acute Disease; Angiotensin II; Animals; Cats; Cerebrovascular Circulation; Chronic Disease; Denervation; Dogs; Higher Nervous Activity; Hypertension, Renal; Ischemia; Ischemic Attack, Transient; Kidney; Norepinephrine; Pressoreceptors; Rabbits; Rats; Spinal Cord; Sympathectomy; Sympathetic Nervous System | 1970 |
5 trial(s) available for angiotensin ii and Acute Disease
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Excess diuresis and natriuresis during acute sleep deprivation in healthy adults.
Topics: Acute Disease; Adolescent; Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Circadian Rhythm; Creatinine; Dinoprostone; Diuresis; Female; Heart Rate; Humans; Male; Melatonin; Natriuresis; Osmolar Concentration; Renin; Renin-Angiotensin System; Sex Factors; Sleep Deprivation; Sodium; Urination Disorders; Young Adult | 2010 |
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Topics: Acute Disease; Adult; Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Heart Rate; Humans; Hypotension, Orthostatic; Kidney Tubules; Lower Body Negative Pressure; Male; Natriuresis; Sodium; Tetrazoles | 2004 |
Atrial natriuretic factor reduces vasopressin and angiotensin II but not the ACTH response to acute hypoglycaemic stress in normal men.
Topics: Acute Disease; Adrenocorticotropic Hormone; Adult; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Corticotropin-Releasing Hormone; Humans; Hypoglycemia; Hypothalamo-Hypophyseal System; Insulin; Male; Pituitary-Adrenal System; Single-Blind Method | 1993 |
Investigations on the renin-angiotensin system in acute severe asthma.
Topics: Acute Disease; Adolescent; Adult; Angiotensin II; Asthma; Catecholamines; Endothelin-1; Female; Forced Expiratory Volume; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Peak Expiratory Flow Rate; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Severity of Illness Index | 1997 |
157 other study(ies) available for angiotensin ii and Acute Disease
| Article | Year |
|---|---|
Ethyl Acetate and Aqueous Fractions of Ziziphus jujuba Prevent Acute Hypertension Induced by Angiotensin II in Rats.
Topics: Acetates; Acute Disease; Angiotensin II; Animals; Hypertension; Male; Plants; Rats; Rats, Wistar; Ziziphus | 2020 |
Losartan promotes myocardial apoptosis after acute myocardial infarction in rats through inhibiting Ang II-induced JAK/STAT pathway.
Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Disease Models, Animal; Injections, Intraperitoneal; Janus Kinase 2; Losartan; Male; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Wistar; STAT3 Transcription Factor | 2020 |
The Possible Regulatory Mechanisms of Aqueous, Ethyl Acetate and NHexane Fractions of the Ribes khorassanicum Extract on Acute Hypertension in Rats.
Topics: Acetates; Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Disease Models, Animal; Hexanes; Hypertension; Losartan; Male; NG-Nitroarginine Methyl Ester; Plant Extracts; Rats; Rats, Wistar; Ribes; Signal Transduction; Water | 2021 |
Expression and role of lumican in acute aortic dissection: A human and mouse study.
Topics: Acute Disease; Aminopropionitrile; Angiotensin II; Animals; Aorta; Aortic Dissection; Aortic Rupture; Biomarkers; Chronic Disease; Disease Models, Animal; Humans; Incidence; Kaplan-Meier Estimate; Lumican; Mice; Mice, Inbred C57BL; Mice, Knockout; Smad2 Protein; Transforming Growth Factor beta; Up-Regulation | 2021 |
Acute Hyperthermia Inhibits TGF-β1-induced Cardiac Fibroblast Activation via Suppression of Akt Signaling.
Topics: Actins; Acute Disease; Angiotensin II; Animals; Disease Models, Animal; Fever; Fibroblasts; Humans; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Myocardium; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta1 | 2018 |
Human umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis.
Topics: Acute Disease; Angiotensin II; Animals; Apoptosis; Culture Media, Conditioned; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Models, Biological; Neovascularization, Physiologic; Pancreas; Pancreatitis; Paracrine Communication; Rats; Umbilical Cord; Vascular Endothelial Growth Factor Receptor-2 | 2019 |
Preparation and antagonistic effect of ACE inhibitory peptide from cashew.
Topics: Acute Disease; Alcohols; Anacardium; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Hepatitis; Humans; Interleukin-6; Male; Mice; Nuts; Peptides; Peptidyl-Dipeptidase A; Plant Extracts; Tumor Necrosis Factor-alpha | 2019 |
Resveratrol suppresses microcirculatory disturbance in a rat model of severe acute pancreatitis.
Topics: Acute Disease; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Endothelins; Microcirculation; Nitric Oxide; Pancreas; Pancreatitis; Rats; Rats, Sprague-Dawley; Renin; Resveratrol; Stilbenes; Taurocholic Acid | 2013 |
Concentration of tissue angiotensin II increases with severity of experimental pancreatitis.
Topics: Acute Disease; Amylases; Angiotensin II; Animals; Disease Models, Animal; Male; Models, Biological; Pancreatitis; Rats; Severity of Illness Index; Taurocholic Acid; Time Factors | 2013 |
Serum levels of renin-angiotensin system components in acute stroke patients.
Topics: Acute Disease; Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Retrospective Studies; Severity of Illness Index; Stroke | 2014 |
Angiotensin-converting enzyme (ACE and ACE2) imbalance correlates with the severity of cerulein-induced acute pancreatitis in mice.
Topics: Acute Disease; Amylases; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Ceruletide; Disease Models, Animal; Genotype; Inflammation Mediators; Male; Mice, Inbred C57BL; Mice, Knockout; Necrosis; Pancreas; Pancreatitis; Peptide Fragments; Peptidyl-Dipeptidase A; Phenotype; Severity of Illness Index; Time Factors | 2014 |
Ulinastatin activates the renin-angiotensin system to ameliorate the pathophysiology of severe acute pancreatitis.
Topics: Acute Disease; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Ceruletide; Disease Models, Animal; Gene Expression; Glycoproteins; Lipopolysaccharides; Mice, Inbred C57BL; Molecular Targeted Therapy; Pancreatitis; Peptide Fragments; Peptidyl-Dipeptidase A; Prospective Studies; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Severity of Illness Index | 2014 |
Adventitial CXCL1/G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture.
Topics: Acute Disease; Adventitia; Aged; Aminopropionitrile; Angiotensin II; Animals; Antibodies, Monoclonal; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Aortic Rupture; Aortography; Chemokine CXCL1; Chemokine CXCL12; Chemotaxis, Leukocyte; Dilatation, Pathologic; Disease Models, Animal; Female; Granulocyte Colony-Stimulating Factor; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neutrophil Activation; Neutrophil Infiltration; Neutrophils; Receptors, Interleukin-8B; Signal Transduction; Time Factors | 2015 |
Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
Topics: Acute Disease; Adult; Aged; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Blood Pressure; Case-Control Studies; Emergencies; Female; Heart Failure; Hospitalization; Humans; Japan; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Regression Analysis; Renin; Renin-Angiotensin System | 2017 |
Captopril pretreatment protects the lung against severe acute pancreatitis induced injury via inhibiting angiotensin II production and suppressing Rho/ROCK pathway.
Topics: Acute Disease; Amylases; Angiotensin II; Animals; Capillary Permeability; Captopril; Humans; Lung; Lung Injury; Male; Organ Size; Pancreas; Pancreatitis; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction | 2016 |
Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats.
Topics: Acute Disease; Analysis of Variance; Angiotensin II; Animals; Chronic Disease; Disease Models, Animal; Flavonoids; Fluorescent Antibody Technique; Heart Failure; Hemodynamics; Immunohistochemistry; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Sympathetic Nervous System | 2008 |
Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.
Topics: Acetylcholine; Acute Disease; Adrenergic Fibers; Angiotensin II; Animals; Calcitonin Gene-Related Peptide; Glucose; Hyperglycemia; Hyperinsulinism; Male; Nitroprusside; Norepinephrine; Octreotide; Rats; Rats, Wistar; Spinal Cord Injuries; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2008 |
Acute hypertension provokes acute trafficking of distal tubule Na-Cl cotransporter (NCC) to subapical cytoplasmic vesicles.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cell Fractionation; Cell Membrane; Cytoplasmic Vesicles; Disease Models, Animal; Diuresis; Hypertension; Infusions, Intravenous; Kidney Tubules, Distal; Male; Microscopy, Immunoelectron; Protein Transport; Rats; Rats, Sprague-Dawley; Receptors, Drug; Sodium Chloride Symporters; Solute Carrier Family 12, Member 3; Symporters; Time Factors | 2009 |
Acute urinary bladder distension triggers ICAM-1-mediated renal oxidative injury via the norepinephrine-renin-angiotensin II system in rats.
Topics: Acute Disease; Angiotensin II; Animals; Female; Intercellular Adhesion Molecule-1; Kidney; Norepinephrine; Oxidative Stress; Rats; Rats, Wistar; Renin-Angiotensin System; Urinary Bladder | 2009 |
Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Fluorescent Antibody Technique; Gelatin; Hypertension; Immunohistochemistry; Intracranial Hemorrhages; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Norepinephrine; Oxidative Stress; Reverse Transcriptase Polymerase Chain Reaction; Stroke; Vasoconstrictor Agents | 2010 |
Effect of acute stress on sexual behavior in female rats: participation of the central angiotensinergic system.
Topics: Acute Disease; Amygdala; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Female; Imidazoles; Losartan; Motor Activity; Oocytes; Proestrus; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Restraint, Physical; Sexual Behavior, Animal; Stress, Psychological; Time Factors | 2010 |
A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Diuresis; Dogs; Glomerular Filtration Rate; Humans; Hypertension; Male; Natriuresis; Pulmonary Wedge Pressure; Renal Circulation; Vascular Resistance | 2010 |
Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection.
Topics: Acute Disease; Aged; Angiotensin II; Animals; Aortic Aneurysm; Aortic Dissection; Disease Models, Animal; Female; Humans; Male; Matrix Metalloproteinase 9; Mice; Middle Aged; Neutrophil Infiltration; Neutrophils | 2012 |
Losartan attenuates renal vasoconstriction in response to acute unilateral ureteral occlusion in pigs.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Glomerular Filtration Rate; Kidney; Losartan; Pelvis; Pressure; Renal Circulation; Swine; Ureteral Obstruction; Vascular Resistance; Vasoconstriction | 2002 |
Haemodynamic and hormonal changes during haemorrhage in conscious dogs treated with an endothelin-A receptor antagonist.
Topics: Action Potentials; Acute Disease; Angiotensin II; Animals; Atrasentan; Blood Pressure; Cardiac Output; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Hemorrhage; Norepinephrine; Pyrrolidines; Random Allocation; Receptor, Endothelin A; Vascular Resistance; Vasodilator Agents; Vasopressins | 2002 |
Diuretic response to acute hypertension is blunted during angiotensin II clamp.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Diuresis; Drug Synergism; Hypertension; Kidney; Lithium; Male; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2 | 2002 |
Angiotensin II clamp prevents the second step in renal apical NHE3 internalization during acute hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Endosomes; Feedback, Physiological; Glomerular Filtration Rate; Hypertension, Renal; Male; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Phosphate Cotransporter Proteins; Sodium-Phosphate Cotransporter Proteins, Type II; Symporters; Vasoconstrictor Agents | 2002 |
Cardiac interstitial bradykinin and mast cells modulate pattern of LV remodeling in volume overload in rats.
Topics: Acute Disease; Angiotensin II; Animals; Aorta; Arteriovenous Fistula; Bradykinin; Cardiac Volume; Cell Count; Chymases; Consciousness; Disease Models, Animal; Extracellular Space; Mast Cells; Microdialysis; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Serine Endopeptidases; Vena Cava, Inferior; Ventricular Remodeling | 2003 |
Angiotensin II and the fibroproliferative response to acute lung injury.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antihypertensive Agents; Bleomycin; Cell Division; Cells, Cultured; Collagen; Fibroblasts; Humans; Losartan; Lung; Peptidyl-Dipeptidase A; Procollagen; Pulmonary Fibrosis; Ramipril; Renin-Angiotensin System; Transforming Growth Factor beta | 2004 |
ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction.
Topics: Acute Disease; Adrenergic alpha-Agonists; Angiotensin II; Animals; Antioxidants; Aorta; Benzimidazoles; Biphenyl Compounds; Cyclic N-Oxides; Enzyme Activation; Heart Ventricles; Hemodynamics; Hypertension; Male; Mitogen-Activated Protein Kinases; Oxidative Stress; Phenylephrine; Prazosin; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Spin Labels; Tetrazoles; Thiobarbituric Acid Reactive Substances; Vasoconstrictor Agents | 2004 |
Acute pancreatitis induced by telmisartan overdose.
Topics: Acute Disease; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Drug Overdose; Humans; Male; Pancreatitis; Telmisartan | 2004 |
Cardiac angiotensin is upregulated in the hearts of unstable angina patients.
Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Electrocardiography; Humans; Male; Middle Aged; Models, Cardiovascular; Myocardium; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2004 |
Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice.
Topics: Acute Disease; Adrenergic alpha-Agonists; Angiotensin II; Animals; Blood Pressure; Heart Rate; Housing, Animal; Hypertension; Inflammation; Interleukin-6; Male; Mesenteric Arteries; Mice; Mice, Knockout; Motor Activity; Norepinephrine; Phenylephrine; Renin; Renin-Angiotensin System; Stress, Psychological; Sympathetic Nervous System; Telemetry; Territoriality | 2004 |
Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Isoproterenol; Lipid Peroxidation; Male; Receptors, Adrenergic, beta; Renin; Renin-Angiotensin System; Sympathomimetics; Ventricular Function, Left | 2004 |
Angiotensin-converting enzyme 2 protects from severe acute lung failure.
Topics: Acids; Acute Disease; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Capillary Permeability; Carboxypeptidases; Disease Models, Animal; Gene Deletion; Humans; Lung; Lung Diseases; Mice; Mice, Knockout; Mice, Transgenic; Oxygen; Peptidyl-Dipeptidase A; Pulmonary Edema; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Respiratory Distress Syndrome; Sepsis; Transgenes | 2005 |
Angiotensin II potentiates inflammatory edema in rats: Role of mast cell degranulation.
Topics: Acute Disease; Angiotensin II; Animals; Anti-Allergic Agents; Carrageenan; Cell Degranulation; Cell Movement; Dextrans; Drug Synergism; Edema; Hindlimb; Inflammation; Interleukin-1beta; Mast Cells; Neutrophils; Peritoneal Cavity; Peroxidase; Pyrilamine; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2006 |
Urea transporter UT-A1 and aquaporin-2 proteins decrease in response to angiotensin II or norepinephrine-induced acute hypertension.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Aquaporin 2; Blood Pressure; Drinking; Hypertension, Renal; Male; Membrane Transport Proteins; Mineralocorticoid Receptor Antagonists; Norepinephrine; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Spironolactone; Thirst; Urea; Urea Transporters; Vasoconstrictor Agents; Water | 2006 |
Reviewer critique of the sympathetic drive after acute myocardial infarction in hypertensive patients.
Topics: Acute Disease; Angiotensin II; Baroreflex; Blood Pressure; Female; Heart; Heart Rate; Humans; Hypertension; Insulin; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Sympathetic Nervous System | 2006 |
Early left ventricular gene expression profile in response to increase in blood pressure.
Topics: Acute Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arginine Vasopressin; bcl-X Protein; Blood Pressure; Cell Cycle Proteins; Chronic Disease; Consciousness; DNA, Complementary; Early Growth Response Protein 1; Eye Proteins; Fatty Acid-Binding Proteins; Gene Expression Profiling; Gene Expression Regulation; Heart Ventricles; HSP70 Heat-Shock Proteins; Hypertension; Losartan; Male; Nerve Growth Factor; Nerve Tissue Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2006 |
Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin.
Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Cell Adhesion Molecules; Cell Communication; Cells, Cultured; Disease Models, Animal; Fibroblasts; Gene Expression Regulation; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Random Allocation; Rats; Rats, Inbred Lew; Rats, Wistar; Stress, Mechanical; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2007 |
Effects of acute stress on the day of proestrus on sexual behavior and ovulation in female rats: participation of the angiotensinergic system.
Topics: Acute Disease; Analysis of Variance; Angiotensin II; Animals; Circadian Rhythm; Corticosterone; Disease Models, Animal; Female; Luteinizing Hormone; Oocytes; Ovulation; Proestrus; Progesterone; Prolactin; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sexual Behavior, Animal; Statistics, Nonparametric; Stress, Psychological | 2007 |
Acute renovascular hypertension in conscious dogs. Interaction of the renin-angiotensin system and sympathetic nervous system in systemic hemodynamics and regional blood flow responses.
Topics: Acute Disease; Angiotensin II; Animals; Catecholamines; Dogs; Hemodynamics; Hypertension, Renal; Hypertension, Renovascular; Phentolamine; Propranolol; Regional Blood Flow; Renal Artery Obstruction; Renin; Sympathetic Nervous System; Teprotide | 1980 |
Acute and chronic systemic and pulmonary hemodynamic effects of angiotensin converting enzyme inhibition with captopril in hypertensive patients.
Topics: Acute Disease; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Output; Chronic Disease; Female; Heart Rate; Hemodynamics; Humans; Hypertension, Renal; Hypertension, Renovascular; Long-Term Care; Lung; Male; Middle Aged; Proline; Stroke Volume; Vascular Resistance | 1980 |
Hyperreninemic hypoaldosteronism in the critically ill: a new entity.
Topics: Acute Disease; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Electrolytes; Female; Humans; Hydrocortisone; Male; Metabolic Clearance Rate; Middle Aged; Renin | 1981 |
Association of hypotension with hyperreninemic hypoaldosteronism in the critically ill patient.
Topics: Acute Disease; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Blood Pressure; Female; Humans; Hydrocortisone; Hypotension; Intensive Care Units; Middle Aged; Renin | 1983 |
Relationships between plasma epinephrine, norepinephrine, dopamine and angiotensin II concentrations, renin activity, hemodynamic state and prognosis in acute heart failure.
Topics: Acute Disease; Adult; Aged; Angiotensin II; Cardiac Output; Catecholamines; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Pulmonary Wedge Pressure; Renin | 1984 |
The role of vascular hypertrophy in early and chronic renovascular hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Female; Hypertension, Renovascular; Hypertrophy; Norepinephrine; Perfusion; Rats; Rats, Inbred Strains; Renal Artery | 1983 |
Different antagonist potency of saralasin in acute and chronic angiotensin-dependent hypertension.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Chronic Disease; Hypertension, Malignant; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Saralasin | 1983 |
Action of renal vasodilators in dogs following acute biliary obstruction.
Topics: Acetylcholine; Acute Disease; Angiotensin II; Animals; Bile; Bradykinin; Cholestasis; Diuresis; Dogs; Dopamine; Female; Furosemide; Glomerular Filtration Rate; Glucagon; Glycine; Inulin; Kidney; Male; Norepinephrine; p-Aminohippuric Acid; Regional Blood Flow; Renal Artery; Vasodilation | 1984 |
Reversibility of blood-brain barrier dysfunction in acute hypertension induced by angiotensin.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Blood-Brain Barrier; Evans Blue; Hypertension; Male; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Effects of acute, angiotensin-induced hypertension on intrarenal arteries in the rat.
Topics: Acute Disease; Angiotensin II; Animals; Arteries; Arterioles; Blood Pressure; Hypertension; Intestines; Kidney; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Permeability; Rats; Rats, Inbred Strains; Renal Circulation; Vasoconstriction | 1984 |
[Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aldosterone; Angiotensin II; Female; Humans; Hypertension; Male; Middle Aged; Renin; Sex Factors | 1980 |
The influence of angiotensin II antagonist postischemic acute renal failure.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Acute Disease; Acute Kidney Injury; Angiotensin II; Animals; Blood Pressure; Dogs; Female; Glomerular Filtration Rate; Kidney; Male; Regional Blood Flow; Renal Artery Obstruction; Renin | 1981 |
Role of renal nerves, angiotensin II, and prostaglandins in the antinatriuretic response to acute hypercapnic acidosis in the dog.
Topics: Acidosis; Acute Disease; Angiotensin II; Animals; Blood Gas Analysis; Blood Pressure; Cardiac Output; Dogs; Female; Filtration; Glomerular Filtration Rate; Hypercapnia; Kidney; Male; Natriuresis; Phenoxybenzamine; Prostaglandins; Sodium | 1982 |
Carotid artery constriction in acute hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Aorta; Blood-Brain Barrier; Carotid Arteries; Cerebrovascular Circulation; Constriction; Hypertension; Male; Permeability; Rats | 1981 |
Effect of acute hypoxia on the pulmonary conversion of angiotensin I to angiotensin II in dogs.
Topics: Acute Disease; Angiotensin I; Angiotensin II; Angiotensins; Animals; Blood Pressure; Carbon Dioxide; Cardiac Output; Dogs; Hydrogen-Ion Concentration; Hypoxia; Injections, Intravenous; Lung; Oxygen; Time Factors; Vasoconstriction | 1980 |
[Infusion of angiotensin II and the changes of posture of the arterial pressure as a means of predicting pregnancy toxemia].
Topics: Acute Disease; Angiotensin II; Female; Humans; Hypertension; Injections, Intravenous; Posture; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third; Prognosis | 1980 |
Angiotensin I conversion and vascular reactivity in pathophysiological states in dogs.
Topics: Acid-Base Imbalance; Acidosis; Acidosis, Respiratory; Acute Disease; Alkalosis; Alkalosis, Respiratory; Angiotensin I; Angiotensin II; Angiotensins; Animals; Dogs; Hypoxia; Vascular Resistance | 1980 |
Tubulointerstitial injury and impaired renal function after recovery from acute puromycin nephrosis.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Glomerular Filtration Rate; Imidazoles; Kidney; Kidney Tubules; Losartan; Male; Natriuresis; Nephrosis; Puromycin; Rats; Tetrazoles; Time Factors | 1995 |
Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Down-Regulation; Gene Expression Regulation; Imidazoles; Kidney; Lisinopril; Losartan; Male; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Ureteral Obstruction | 1994 |
Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function.
Topics: Acute Disease; Adult; Angiotensin II; Asthma; Blood Pressure; Bronchoconstriction; Chronic Disease; Female; Forced Expiratory Volume; Humans; Male; Oxygen; Renin; Renin-Angiotensin System; Sodium | 1994 |
Role of angiotensin II in renal vasoconstriction with acute hypoxemia and hypercapnic acidosis in conscious dogs.
Topics: Acidosis, Respiratory; Acute Disease; Angiotensin II; Animals; Blood Pressure; Dogs; Hypoxia; Kidney; Renal Circulation; Vascular Resistance; Vasoconstriction | 1994 |
Alterations of cerebromicrovascular Na+,K(+)-ATPase activity due to fatty acids and acute hypertension.
Topics: 4-Nitrophenylphosphatase; Acute Disease; Angiotensin II; Animals; Arachidonic Acid; Brain; Capillaries; Cerebrovascular Circulation; Fatty Acids; Fatty Acids, Unsaturated; gamma-Glutamyltransferase; Hypertension; Male; Phosphoric Monoester Hydrolases; Potassium; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase | 1993 |
Acute hypoxia increases cytosolic calcium in fetal pulmonary artery smooth muscle cells.
Topics: Acute Disease; Angiotensin II; Animals; Calcium; Carotid Arteries; Cells, Cultured; Cytosol; Fetus; Hypoxia; Muscle, Smooth, Vascular; Pulmonary Artery | 1993 |
Cardiovascular and catecholamine responses to acute haemorrhage in anaesthetized potassium-adapted rats.
Topics: Acute Disease; Adaptation, Physiological; Anesthesia; Angiotensin II; Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Catecholamines; Hemodynamics; Hemorrhage; Infusions, Intravenous; Male; Norepinephrine; Potassium; Rats; Rats, Sprague-Dawley; Vasopressins | 1993 |
Low-dose atrial natriuretic factor and furosemide in experimental acute congestive heart failure.
Topics: Acute Disease; Angiotensin II; Animals; Atrial Natriuretic Factor; Dogs; Drug Synergism; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Male; Natriuresis; Pulmonary Edema; Renin-Angiotensin System | 1993 |
Renin-angiotensin system stimulates respiration during acute hypotension but not during hypercapnia.
Topics: Acute Disease; Angiotensin II; Animals; Arginine Vasopressin; Blood Glucose; Blood Pressure; Dogs; Hypercapnia; Hypotension; Male; Nitroprusside; Osmolar Concentration; Oxygen Consumption; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Respiration; Saralasin | 1993 |
During acute hypercapnia vasopressin inhibits an angiotensin drive to ventilation in conscious dogs.
Topics: Acid-Base Equilibrium; Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Dogs; Fluid Shifts; Hemodynamics; Hypercapnia; Infusions, Intravenous; Male; Renin; Respiration; Saralasin | 1995 |
Acute hypertension activates mitogen-activated protein kinases in arterial wall.
Topics: Acute Disease; Angiotensin II; Animals; Aorta; Base Sequence; Calcium-Calmodulin-Dependent Protein Kinases; DNA Primers; Enzyme Activation; Gene Expression; Genes, fos; Genes, jun; Hypertension; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Phenylephrine; Rats; Rats, Wistar; Restraint, Physical; RNA, Messenger; Transcription Factor AP-1; Up-Regulation | 1996 |
Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction.
Topics: Acetylcholinesterase; Acute Disease; Angiotensin II; Animals; Gene Expression; Kidney; Male; Rats; Rats, Wistar; Receptors, Angiotensin; Renal Circulation; Renin; Renin-Angiotensin System; RNA, Messenger; Time Factors; Ureteral Obstruction | 1995 |
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion.
Topics: Acute Disease; Angiotensin II; Animals; Blood Vessels; Cardiac Output; Compliance; Coronary Circulation; Disease Models, Animal; Dogs; Female; Hemodynamics; Hypertension; Male; Myocardial Infarction; Myocardial Ischemia; Vascular Resistance | 1996 |
Increased vascular collagen and noncollagenous protein synthesis contributes to sustain chronic phase of two-kidney, one-clip renovascular hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Chronic Disease; Collagen; Hypertension, Renovascular; Male; Rats; Rats, Wistar; Renin | 1996 |
Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Chlorisondamine; Chronic Disease; Dose-Response Relationship, Drug; Ganglionic Blockers; Hypertension; Imidazoles; Losartan; Male; Nervous System Physiological Phenomena; Rats; Rats, Sprague-Dawley; Tetrazoles | 1996 |
Variation of intrarenal angiotensin II and angiotensin II receptors by acute renal ischemia in the aged rat.
Topics: Acute Disease; Aging; Angiotensin II; Animals; Creatinine; Ischemia; Kidney; Kidney Glomerulus; Male; Random Allocation; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger | 1996 |
Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect?
Topics: Acute Disease; Albuminuria; Aminopeptidases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Enalapril; Glutamyl Aminopeptidase; Histocytochemistry; Imidazoles; In Situ Hybridization; Losartan; Mice; Mice, Inbred BALB C; Tetrazoles | 1996 |
Use of pulsed-wave Doppler echocardiography to measure changes in MPAP. Is further validation required?
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Captopril; Echocardiography, Doppler, Pulsed; Heart; Humans; Hypertension, Pulmonary; Hypoxia; Imidazoles; Losartan; Lung Diseases, Obstructive; Pulmonary Artery; Pulmonary Heart Disease; Rats; Renin-Angiotensin System; Reproducibility of Results; Tetrazoles; Vasoconstriction | 1997 |
Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cardiovascular System; Cells, Cultured; Data Interpretation, Statistical; Enzyme Activation; Gene Expression Regulation, Enzymologic; Hypertension; Male; Mitogens; Muscle, Smooth, Vascular; Nitroprusside; Phenylephrine; Phosphoprotein Phosphatases; Protein Kinases; Protein Phosphatase 1; Rats; Rats, Wistar; Restraint, Physical; RNA; Stress, Physiological; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1997 |
Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Heart Rate; Hemodynamics; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Inbred SHR | 1997 |
Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enhancer Elements, Genetic; Enzyme Activation; Hypertension; Janus Kinase 2; Myocardium; Phosphoproteins; Precipitin Tests; Protein-Tyrosine Kinases; Proteins; Proto-Oncogene Proteins; Rats; Rats, Wistar; Trans-Activators; TYK2 Kinase | 1997 |
Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol.
Topics: Acute Disease; Angiotensin II; Animals; Antihypertensive Agents; Cerebral Hemorrhage; Cerebral Infarction; Hypertension; Intracranial Embolism and Thrombosis; Labetalol; Male; Rabbits | 1998 |
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Topics: Acute Disease; Adrenergic beta-Agonists; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dobutamine; Dogs; Female; Heart Conduction System; Heart Failure; Heart Rate; Hemodynamics; Male; Nicardipine; Nitroglycerin; Vasodilator Agents | 1998 |
Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chronic Disease; Denervation; Enzyme Inhibitors; Hypertension; Injections, Intravenous; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phentolamine; Rats; Rats, Wistar; Sinoatrial Node; Tetrazoles | 1998 |
Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension.
Topics: Acute Disease; Angiotensin I; Angiotensin II; Animals; Blotting, Western; Down-Regulation; Female; Gene Expression Regulation; Hypertension; Hypertension, Renal; Immunohistochemistry; Kidney; Kidney Glomerulus; Kidney Tubules; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1999 |
Mediation of humoral catecholamine secretion by the renin-angiotensin system in hypotensive rainbow trout (Oncorhynchus mykiss).
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output; Catecholamines; Female; Hypotension; Lisinopril; Male; Oncorhynchus mykiss; Papaverine; Parasympatholytics; Radioimmunoassay; Renin-Angiotensin System; Reproducibility of Results; Vascular Resistance | 1999 |
Differentiation of the peptidergic vasoregulatory response to standardized splanchnic hypoperfusion by acute hypovolaemia or sepsis in anaesthetized pigs.
Topics: Acute Disease; Anesthesia; Angiotensin II; Animals; Atrial Natriuretic Factor; Endothelin-1; Escherichia coli Infections; Female; Femoral Vein; Hemorrhage; Hypovolemia; Male; Neuropeptides; Portal Vein; Sepsis; Splanchnic Circulation; Swine; Vasoconstrictor Agents | 1999 |
Larger anastomoses in angiotensinogen-knockout mice attenuate early metabolic disturbances after middle cerebral artery occlusion.
Topics: Acute Disease; Adenosine Triphosphate; Angiotensin II; Animals; Anterior Cerebral Artery; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Circulation; Collateral Circulation; Female; Infarction, Middle Cerebral Artery; Latex; Mice; Mice, Knockout; Middle Cerebral Artery; Renin-Angiotensin System; Stroke | 1999 |
Participation of angiotensin receptors in acute hypoxia in mice. II. Effects of angiotensin II nonpeptide receptor ligands losartan (DuP-753) and PD-123319.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Dose-Response Relationship, Drug; Hypoxia, Brain; Imidazoles; Injections, Intraventricular; Ligands; Losartan; Male; Mice; Mice, Inbred ICR; Pyridines; Receptors, Angiotensin; Seizures; Vasoconstrictor Agents | 1999 |
Contribution of angiotensin II to late renal injury after acute ischemia.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Enalapril; Ischemia; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors | 2000 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water | 2000 |
Release of nitric oxide after acute hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Aorta, Thoracic; Enzyme Inhibitors; Hypertension; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Phenylephrine; Rats; Rats, Wistar; Vasoconstrictor Agents | 2000 |
Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Blood Pressure; Cardiomegaly; Chronic Disease; DNA; Heart Rate; Hypertension; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Organ Size; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Transcription Factor AP-1 | 2000 |
Acute hypertension inhibits thirst stimulated by ANG II, hyperosmolality, or hypovolemia in rats.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Drinking; Drinking Behavior; Endothelin-1; Hypertension; Hypovolemia; Infusions, Intravenous; Male; Osmotic Pressure; Phenylephrine; Polyethylene Glycols; Potassium; Pressoreceptors; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Sodium; Solvents; Thirst; Urine; Vasoconstrictor Agents | 2001 |
Evidence that the renin decrease during hypoxia is adenosine mediated in conscious dogs.
Topics: Acute Disease; Adenosine; Aldosterone; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Carbon Dioxide; Consciousness; Diet, Sodium-Restricted; Dogs; Female; Heart Rate; Hemodynamics; Hypoxia; Oxygen; Partial Pressure; Potassium; Purinergic P1 Receptor Antagonists; Renin; Renin-Angiotensin System; Theophylline | 2001 |
Angiotensin II AT(1A) receptor antisense lowers blood pressure in acute 2-kidney, 1-clip hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Autoradiography; Binding, Competitive; Blood Pressure; Body Weight; DNA, Antisense; Dose-Response Relationship, Drug; Hypertension, Renovascular; Kidney Medulla; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sodium; Time Factors; Tissue Distribution | 2001 |
Early changes of arginine vasopressin and angiotensin II in patients with acute cerebral injury.
Topics: Acute Disease; Adolescent; Adult; Aged; Angiotensin II; Arginine Vasopressin; Brain Injuries; Female; Humans; Male; Middle Aged | 2001 |
Reversibility of the blood-brain barrier dysfunction induced by acute hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Blood-Brain Barrier; Hydrogen-Ion Concentration; Hypertension; Male; Partial Pressure; Rats | 1978 |
Blood-brain barrier to albumin in awake rats in acute hypertension induced by adrenaline, noradrenaline or angiotensin.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Blood-Brain Barrier; Epinephrine; Hydrogen-Ion Concentration; Hypertension; Male; Norepinephrine; Rats; Serum Albumin, Radio-Iodinated | 1979 |
[Relationship between the kininase- and angiotensin- converting activity under normal conditions and in experimental myocardial infarct].
Topics: Acute Disease; Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Carboxypeptidases; Injections, Intra-Arterial; Injections, Intravenous; Kallidin; Lysine Carboxypeptidase; Male; Myocardial Infarction; Peptidyl-Dipeptidase A; Rats; Unithiol | 1977 |
[Laboratory diagnosis of renal diseases. XXI. Renal hypertension].
Topics: Acute Disease; Angiotensin II; Blood Vessels; Chronic Disease; Glomerulonephritis; Humans; Hypertension, Renal; Kidney; Kidney Neoplasms; Pyelonephritis; Renin; Sodium; Sympathetic Nervous System; Urography | 1975 |
[Renin-angiotensin-aldosterone system in acute embologenic arterial obstruction].
Topics: Acute Disease; Adult; Aged; Aldosterone; Angiotensin II; Arterial Occlusive Diseases; Embolism; Erythrocytes; Female; Humans; Ischemia; Leg; Male; Middle Aged; Potassium; Renin; Sodium; Time Factors | 1979 |
Effects of acute hypotension and hypertension on serum TSH concentrations in male rats.
Topics: Acute Disease; Angiotensin II; Animals; Clonidine; Dihydralazine; Hypertension; Hypotension; Male; Nitroprusside; Norepinephrine; Rats; Sodium Chloride; Thyrotropin | 1979 |
Effects of angiotensen antagonist in rats with acute, subacute, and chronic two-kidney renal hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Chronic Disease; Hypertension, Renal; Male; Rats; Renin; Saralasin | 1978 |
Continuous angiotensin II blockade throughout the acute phase of one-kidney hypertension in the dog.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Constriction; Dogs; Female; Hypertension, Renal; Infusions, Parenteral; Renal Artery; Renin; Teprotide; Time Factors | 1978 |
[Renin and various factors of its regulation in acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Aldosterone; Angiotensin II; Homeostasis; Humans; Hypokalemia; Male; Middle Aged; Myocardial Infarction; Potassium; Renin | 1978 |
Renal hemodynamics in acute and chronic angiotensin II hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Body Fluids; Chronic Disease; Dogs; Glomerular Filtration Rate; Hemodynamics; Hypertension, Renal; Kidney; Male | 1978 |
Prostaglandin-mediated hyperemia and renin-mediated hypertension during acute ureteral obstruction.
Topics: Acute Disease; Angiotensin II; Animals; Dogs; Female; Hyperemia; Hypertension; Indomethacin; Kidney; Male; Meclofenamic Acid; Prostaglandins; Renin; Ureter; Ureteral Obstruction | 1978 |
Cerebral cortical changes in acute experimental hypertension: An ultrastructural study.
Topics: Acute Disease; Angiotensin II; Animals; Brain Edema; Cerebral Cortex; Diffusion; Female; Horseradish Peroxidase; Hypertension; Rats; Trypan Blue | 1977 |
The role of intrarenal angiotensin II in the hemodynamic response to unilateral obstructive uropathy.
Topics: Acute Disease; Angiotensin II; Animals; Chronic Disease; Dogs; Female; Glomerular Filtration Rate; Kidney; Regional Blood Flow; Renin; Saralasin; Ureteral Obstruction; Vascular Resistance | 1977 |
The effects of propranolol on acute hypertension of anesthetized dogs and on the carotid sinus reflex responses of anesthetized and awake dogs.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Carotid Artery, External; Carotid Sinus; Denervation; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension; Hypothalamus, Middle; Male; Myocardial Contraction; Norepinephrine; Propranolol; Vagotomy | 1977 |
Brain energy metabolism in angiotensin-induced acute hypertension in rats.
Topics: Acute Disease; Ammonia; Angiotensin II; Animals; Blood-Brain Barrier; Brain; Energy Metabolism; Glucose; Glycogen; Hypertension; Ischemic Attack, Transient; Male; Organophosphorus Compounds; Rats; Rats, Inbred Strains | 1977 |
Penetration of fluorescent homologous serum proteins into the wall of the aorta in rats with acute angiotensin hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Aorta; Blood Proteins; Female; Fluorescence; Hypertension; Rats | 1976 |
The clinical effect of acute blood pressure increase in conscious rats. A comparison between normotensive and spontaneously hypertensive rats.
Topics: Acute Disease; Angiotensin II; Animals; Aorta, Thoracic; Blood Pressure; Blood-Brain Barrier; Consciousness; Dihydralazine; Hypertension; Male; Rats; Seizures | 1976 |
Increased vascular permeability for plasma components during acute angiotensin hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Aorta; Arteries; Blood Proteins; Coronary Vessels; Hypertension; Kidney; Permeability; Rats; Vascular Resistance | 1976 |
Ultrastructural arteriolar lesions and permeability changes in acute angiotensin-induced hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Arteries; Cell Membrane Permeability; Hypertension; Intestine, Small; Rats; Vascular Diseases; Vascular Resistance | 1976 |
Dissociation between indices of pump performance and contractility in patients with coronary artery disease and acute myocardial infarction.
Topics: Acute Disease; Angiocardiography; Angiotensin II; Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Exercise Test; Heart; Heart Rate; Heart Ventricles; Humans; Indicator Dilution Techniques; Models, Biological; Myocardial Infarction | 1975 |
Evidence for a significant contribution from central effects of angiotensin in the development of acute renal hypertension in the greyhound.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Constriction; Dogs; Hypertension, Renal; Kidney; Norepinephrine; Regional Blood Flow; Renal Artery; Renin; Time Factors | 1975 |
[State of the renin-angiotensin system in acute and chronic circulatory insufficiency].
Topics: Acute Disease; Angiotensin II; Blood Circulation; Chronic Disease; Coronary Disease; Hemodynamics; Humans; Renin | 1975 |
[Involvement of the Renin-angiotensin system in experimental hyper-tensions, demonstrated by a new specific angiotensin II antagonist].
Topics: Acute Disease; Angiotensin II; Animals; Chronic Disease; Hypertension, Renal; Male; Rats; Renin | 1975 |
The renin-angiotensin system in patients with acute respiratory insufficiency.
Topics: Acute Disease; Angiotensin II; Humans; Renin; Respiratory Insufficiency | 1976 |
Sympathetic control of cerebral blood flow in acute arterial hypertension.
Topics: Acute Disease; Angiotensin II; Animals; Aorta; Aorta, Thoracic; Blood Flow Velocity; Blood Pressure; Blood-Brain Barrier; Cats; Cerebrovascular Circulation; Electric Stimulation; Female; Hypertension; Male; Metaraminol; Sympathetic Nervous System; Vagus Nerve; Vasomotor System | 1976 |
Raised plasma concentrations of endothelin-1 and -3 in marmosets with acute aortic stenosis: no relation to the renin-angiotensin system.
Topics: Acute Disease; Angiotensin II; Animals; Aortic Valve Stenosis; Blood Pressure; Callithrix; Carotid Arteries; Chromatography, High Pressure Liquid; Enalaprilat; Endothelins; Female; Femoral Artery; Male; Osmolar Concentration; Renin; Renin-Angiotensin System | 1992 |
Role of intrarenal angiotensin II and alpha-adrenoceptors in renal vasoconstriction with acute hypoxemia and hypercapnic acidosis in conscious dogs.
Topics: Acidosis; Acute Disease; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Dogs; Hypercapnia; Hypoxia; Kidney; Pharmaceutical Vehicles; Phenylephrine; Prazosin; Receptors, Adrenergic, alpha; Renal Circulation; Saralasin; Vasoconstriction | 1991 |
Lung injury in acute experimental pancreatitis in rats. II. Functional studies.
Topics: Acute Disease; Angiotensin II; Animals; Capillary Permeability; Ceruletide; Hypoxia; Lung; Male; Organ Size; Pancreatitis; Rats; Rats, Inbred Strains; Respiratory Distress Syndrome; Vascular Resistance; Vasoconstriction | 1991 |
Systemic and regional effects of vasopressin and angiotensin in acute left ventricular failure.
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Blood Pressure; Cardiac Output, Low; Electroshock; Female; Heart Ventricles; Hemodynamics; Hormones; Male; Rabbits; Receptors, Vasopressin; Regional Blood Flow; Vasopressins | 1991 |
[Neurohumoral and functional determinants of destabilization in patients with acute forms of ischemic heart disease].
Topics: Acute Disease; Angiotensin II; beta-Thromboglobulin; Coronary Disease; Epoprostenol; Fibrinopeptide A; Humans; Physical Exertion; Radioimmunoassay; Thromboxane A2; Vasopressins | 1991 |
Role of oxygen-derived free radicals in acute angiotensin II--induced hypertensive vascular disease in the rat.
Topics: Acute Disease; Angiotensin II; Animals; Arteries; Endothelium, Vascular; Free Radicals; Hypertension; Intestines; Male; Microscopy, Electron; Muscle, Smooth, Vascular; Oxygen; Rats; Rats, Inbred Strains | 1990 |
The renal antihypertensive effect of angiotensin I converting enzyme inhibitors.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Female; Heart Rate; Hypertension; Indomethacin; Kidney; Norepinephrine; Rabbits; Saralasin | 1987 |
Reduced plasma noradrenaline during angiotensin II-induced acute hypertension in man.
Topics: Acute Disease; Adult; Aged; Angiotensin II; Blood Pressure; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine | 1985 |
Neuroendocrine response in acute heart failure and the influence of treatment.
Topics: Acute Disease; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Catecholamines; Cyclic GMP; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Neurotransmitter Agents | 1989 |
Acute aortic coarctation hypertension: role of vasopressin and angiotensin II.
Topics: Acute Disease; Angiotensin II; Animals; Aortic Coarctation; Arginine Vasopressin; Blood Pressure; Carotid Arteries; Heart Rate; Hypertension; Male; Rats; Rats, Inbred Strains; Saralasin; Vasopressins | 1989 |
Renal response to hemorrhage in dogs with subacute biliary obstruction.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Angiotensin II; Animals; Cardiac Output; Cholestasis; Dogs; Female; Glomerular Filtration Rate; Hemodynamics; Hemorrhage; Kidney; Kidney Function Tests; Male; p-Aminohippuric Acid; Time Factors | 1985 |
Cardiovascular baroreceptor control during angiotensin-induced acute hypertension in the dog.
Topics: Acute Disease; Angiotensin II; Animals; Carotid Sinus; Dogs; Hemodynamics; Hypertension; Isoflurane; Pressoreceptors; Regional Blood Flow; Vascular Resistance | 1988 |
Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat.
Topics: Acute Disease; Angiotensin II; Animals; Blood Vessels; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Infusions, Intravenous; Male; Pulmonary Circulation; Rats; Rats, Inbred Strains | 1988 |
Participation of the renin-angiotensin system in the captopril-induced worsening of anemia in chronic hemodialysis patients.
Topics: Acute Disease; Adult; Anemia; Angiotensin II; Blood Cell Count; Captopril; Erythropoiesis; Female; Hematocrit; Hemoglobins; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Renin-Angiotensin System | 1986 |
Role of 5-hydroxytryptamine in endotoxin-induced respiratory failure of pigs.
Topics: Acute Disease; Angiotensin II; Animals; Bronchi; Constriction, Pathologic; Dinoprost; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Ketanserin; Norepinephrine; Prostaglandins F; Pulmonary Artery; Pulmonary Veins; Respiratory Insufficiency; Serotonin; Swine; Swine Diseases; Vascular Resistance | 1987 |
[Plasma angiotensin II of patients with cor pulmonale in its acute stage].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angiotensin II; Female; Humans; Male; Middle Aged; Pulmonary Heart Disease; Radioimmunoassay | 1986 |
Role of angiotensin in lethal cerebral hypoperfusion during treatment of acute hypertension.
Topics: Acute Disease; Adult; Angiotensin II; Blood Pressure; Cerebral Angiography; Cerebral Arteries; Humans; Hypertension; Ischemic Attack, Transient; Male; Nitroprusside; Perfusion; Vasoconstriction | 1985 |
Systemic and renal hemodynamic changes during acute unilateral renal arterial stenosis.
Topics: Acute Disease; Angiotensin II; Animals; Arterial Occlusive Diseases; Autonomic Nervous System; Constriction, Pathologic; Dogs; Hemodynamics; Male; Renal Artery; Renal Circulation; Vascular Resistance | 1985 |
Pathogenesis of hypertensive encephalopathy.
Topics: Acute Disease; Aged; Angiotensin II; Animals; Blood Pressure; Brain Diseases; Carbon; Carbon Dioxide; Cats; Cerebrovascular Circulation; Dogs; Humans; Hypertension; Male; Middle Aged; Muscle, Smooth; Oxygen Consumption; Papio; Partial Pressure; Radioisotopes; Xenon | 1973 |
[Clinical and morphological aspects of acute renal hypertension in panarteritis nodosa (author's transl)].
Topics: Acute Disease; Adrenal Cortex Hormones; Angiotensin II; Female; Humans; Hypertension, Renal; Middle Aged; Polyarteritis Nodosa; Renin | 1974 |
Antihypertensive effect of an isolated phospholipid.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Depression, Chemical; Hypertension, Renal; Intestinal Absorption; Kidney; Nephrectomy; Phospholipids; Rats; Renin | 1968 |
Production of Arneil-Dekanski factor in vitro by plasma of renal hypertensive rats.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Hypertension, Renal; Kidney; Male; Nephrectomy; Plasma; Rats; Renal Artery; Vasoconstrictor Agents | 1968 |
Derangement of regional cerebral blood flow and of its regulatory mechanisms in acute cerebrovascular lesions.
Topics: Acute Disease; Adult; Aged; Angiotensin II; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cerebral Angiography; Cerebral Arteries; Cerebral Hemorrhage; Cerebrovascular Disorders; Dilatation; Electroencephalography; Humans; Hypercapnia; Hyperemia; Hypertension; Ischemic Attack, Transient; Middle Aged; Partial Pressure; Vasomotor System; Veins | 1968 |
Acute renal vein hypertension: oliguria, hormone infusion, and volume expansion.
Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Anuria; Dogs; Glomerular Filtration Rate; Hypertension, Renal; Kidney; Liver Cirrhosis; Male; Organ Size; Renal Veins; Renin; Sodium; Vasopressins | 1969 |
Treatment of acute ischemic pain in the leg by induced hypertension.
Topics: Acute Disease; Adult; Aged; Analgesics; Angiotensin II; Female; Humans; Hypertension; Injections, Intravenous; Intermittent Claudication; Ischemia; Leg; Male; Middle Aged; Thrombosis | 1969 |
The vascular responses of the spleen to intravenous infusions of catecholamines, angiotensin and vasopressi in the anaesthetized cat.
Topics: Acute Disease; Anesthesia, Intravenous; Angiotensin II; Animals; Catecholamines; Cats; Constriction; Hemorrhage; Injections, Intravenous; Muscle, Smooth; Organ Size; Pentobarbital; Regional Blood Flow; Spleen; Vasopressins | 1970 |
Another humoral substance that enhances adrenergic responsiveness during acute renal ischaemia.
Topics: Acute Disease; Angiotensin II; Animals; Constriction; Dogs; Drug Synergism; Hindlimb; Ischemia; Kidney; Norepinephrine; Sympathetic Nervous System; Vasomotor System | 1971 |
[The epidermolysis syndrome (Lyell) from the viewpoint of internal medicine].
Topics: Acute Disease; Aged; Angiotensin II; Cardiomegaly; Cholangitis; Chronic Disease; Diabetes Complications; Glomerulonephritis; Humans; Liver Cirrhosis; Male; Methicillin; Middle Aged; Pancreatic Diseases; Potassium; Prednisolone; Prognosis; Stevens-Johnson Syndrome | 1970 |
[Changes of serum angiotensionogen concentration in acute hepatitis and liver cirrhosis].
Topics: Acute Disease; Angiotensin II; Hepatitis A; Humans; Liver Cirrhosis; Renin | 1972 |
Shock in acute pancreatitis and hypovolaemia.
Topics: Acute Disease; Angiotensin II; Animals; Blood Volume; Dogs; Hypotension; Macroglobulins; Pancreatitis; Shock; Trypsin | 1972 |
A clinical test useful for predicting the development of acute hypertension in pregnancy.
Topics: Acute Disease; Angiotensin II; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Infusions, Parenteral; Methods; Posture; Pregnancy; Pregnancy Complications, Cardiovascular; Time Factors | 1974 |
Effect of blockade of angiotensin-I converting enzyme on the blood pressure of renal hypertensive rabbits.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Chronic Disease; Hypertension, Renal; Infusions, Parenteral; Male; Nephrectomy; Peptides; Rabbits; Renal Artery Obstruction | 1974 |
The kidney factors in the production of acute hypertensive vascular lesions.
Topics: Acute Disease; Angiotensin II; Animals; Arteries; Edema; Female; Fluorescent Antibody Technique; Hypertension; Injections; Kidney Cortex; Lysosomes; Mitochondria; Necrosis; Nephrectomy; Pancreas; Pleural Effusion; Rabbits; Rats; Renin; Solubility; Subcellular Fractions; Tissue Extracts; Vascular Diseases | 1974 |
Renin-angiotensin I activity in renin lymph during acute ureteral obstruction.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Dogs; Hypertension, Renal; Renin; Ureteral Obstruction | 1974 |
Regional cerebral blood flow and intraventricular pressure in acute head injuries.
Topics: Acute Disease; Adolescent; Adult; Angiotensin II; Blood Pressure; Carbon Dioxide; Cerebrovascular Circulation; Child; Craniocerebral Trauma; Humans; Hypnotics and Sedatives; Intracranial Pressure; Lactates; Middle Aged; Oxygen; Prognosis; Pyruvates; Radioisotopes; Respiration, Artificial; Trimethaphan; Vasomotor System; Xenon | 1974 |
[Experimental, acute renal hypertension and exogenous angiotensin II administration following premedication with the prostaglandin biosynthesis inhibitor indometacin].
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Dogs; Hypertension, Renal; Indomethacin; Premedication; Prostaglandin Antagonists; Prostaglandins; Rats | 1974 |
Cardiovascular reactivity in acute and chronic renal hypertensive dogs.
Topics: Acute Disease; Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Chronic Disease; Dogs; Hindlimb; Hypertension; Hypertension, Renal; Reference Values; Vasoconstriction | 1966 |